News
APUS
1.410
+5.22%
0.070
Weekly Report: what happened at APUS last week (0302-0306)?
Weekly Report · 3d ago
Weekly Report: what happened at APUS last week (0223-0227)?
Weekly Report · 03/02 09:42
Weekly Report: what happened at APUS last week (0216-0220)?
Weekly Report · 02/23 09:41
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 02/19 17:05
Weekly Report: what happened at APUS last week (0209-0213)?
Weekly Report · 02/16 09:41
Apimeds, FDA to Discuss Bee Venom Treatment for Osteoarthritis
Dow Jones · 02/11 22:48
Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate
TipRanks · 02/11 21:55
Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment
Benzinga · 02/11 21:53
Weekly Report: what happened at APUS last week (0202-0206)?
Weekly Report · 02/09 09:43
Weekly Report: what happened at APUS last week (0126-0130)?
Weekly Report · 02/02 09:42
Weekly Report: what happened at APUS last week (0119-0123)?
Weekly Report · 01/26 09:42
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 01/22 21:05
Weekly Report: what happened at APUS last week (0112-0116)?
Weekly Report · 01/19 09:46
Weekly Report: what happened at APUS last week (0105-0109)?
Weekly Report · 01/12 09:44
Weekly Report: what happened at APUS last week (1229-0102)?
Weekly Report · 01/05 09:42
Apimeds Pharmaceuticals Reshapes Board After Director Removal
TipRanks · 01/02 22:00
Weekly Report: what happened at APUS last week (1222-1226)?
Weekly Report · 12/29/2025 09:41
Weekly Report: what happened at APUS last week (1215-1219)?
Weekly Report · 12/22/2025 09:41
Weekly Report: what happened at APUS last week (1208-1212)?
Weekly Report · 12/15/2025 09:45
Apimeds Pharmaceuticals Announces Board Members’ Resignation
TipRanks · 12/10/2025 14:48
More
Webull provides a variety of real-time APUS stock news. You can receive the latest news about APIMEDS PHARMACEUTICALS US INC through multiple platforms. This information may help you make smarter investment decisions.
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.